These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 18497513)
1. Increased CD4CD25+FOXP3+ regulatory T Cells in cancer patients from conversion of CD4+CD25- T cells through tumor-derived factors. Mao C; Wang S; Jiang Q; Tong J; Ma J; Yang M; Xu X; Qiu G; Shao Q; Li L; Xu H Onkologie; 2008 May; 31(5):243-8. PubMed ID: 18497513 [TBL] [Abstract][Full Text] [Related]
2. Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination. Nakai N; Katoh N; Kitagawa T; Ueda E; Takenaka H; Kishimoto S J Dermatol Sci; 2009 Apr; 54(1):31-7. PubMed ID: 19157789 [TBL] [Abstract][Full Text] [Related]
3. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression. Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062 [TBL] [Abstract][Full Text] [Related]
4. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169 [TBL] [Abstract][Full Text] [Related]
5. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients. Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383 [TBL] [Abstract][Full Text] [Related]
6. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820 [TBL] [Abstract][Full Text] [Related]
7. Defective functions of circulating CD4+CD25+ and CD4+CD25- T cells in patients with chronic ordinary urticaria. Chen WC; Chiang BL; Liu HE; Leu SJ; Lee YL J Dermatol Sci; 2008 Aug; 51(2):121-30. PubMed ID: 18440785 [TBL] [Abstract][Full Text] [Related]
8. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917 [TBL] [Abstract][Full Text] [Related]
9. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice. Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957 [TBL] [Abstract][Full Text] [Related]
10. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells. Leveque L; Deknuydt F; Bioley G; Old LJ; Matsuzaki J; Odunsi K; Ayyoub M; Valmori D J Immunother; 2009; 32(2):101-8. PubMed ID: 19238008 [TBL] [Abstract][Full Text] [Related]
11. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast. Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429 [TBL] [Abstract][Full Text] [Related]
12. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Ichihara F; Kono K; Takahashi A; Kawaida H; Sugai H; Fujii H Clin Cancer Res; 2003 Oct; 9(12):4404-8. PubMed ID: 14555512 [TBL] [Abstract][Full Text] [Related]
13. Hyperthermia and irradiation of head and neck squamous cancer cells causes migratory profile changes of tumour infiltrating lymphocytes. Schmidtner J; Distel LV; Ott OJ; Nkenke E; Sprung CN; Fietkau R; Lubgan D Int J Hyperthermia; 2009 Aug; 25(5):347-54. PubMed ID: 19479600 [TBL] [Abstract][Full Text] [Related]
14. Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Yuan XL; Chen L; Li MX; Dong P; Xue J; Wang J; Zhang TT; Wang XA; Zhang FM; Ge HL; Shen LS; Xu D Clin Immunol; 2010 Mar; 134(3):277-88. PubMed ID: 19900843 [TBL] [Abstract][Full Text] [Related]
15. Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Meloni F; Morosini M; Solari N; Passadore I; Nascimbene C; Novo M; Ferrari M; Cosentino M; Marino F; Pozzi E; Fietta AM Hum Immunol; 2006; 67(1-2):1-12. PubMed ID: 16698419 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human. Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651 [TBL] [Abstract][Full Text] [Related]
17. [Study on ratio imbalance of peripheral blood Th17/Treg cells in patients with rheumatoid arthritis]. Niu Q; Huang ZC; Cai B; Wang LL; Feng WH Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Mar; 26(3):267-9, 272. PubMed ID: 20230694 [TBL] [Abstract][Full Text] [Related]